The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Jones Day

Dr Olga Bezzubova

Tel:
Work +49 89 20 60 42 240
Email:
Jones Day

Work Department

Intellectual Property; Patent Prosecution & IP Counseling; Life Sciences IP; Life Sciences.

Position

Dr. Olga Bezzubova, Partner, focuses her practice on intellectual property law in the life science and pharmaceutical industries.

Career

Prior to joining Jones Day, Olga worked for more than 13 years at a German patent law firm. She advises on all aspects of patent prosecution and opposition proceedings, patent validity, and infringement. Olga's training in physics and biology allows her to counsel clients in matters involving various aspects of biotechnology, cell biology, immunology, genomics, proteomics, molecular biology, food science, biopharmaceuticals, biophysics, as well as technologies emerging in the technical convergence of biological and physical sciences. Olga has authored and coauthored numerous publications in molecular genetics and IP. She also has taught IP classes at the Institute for Machine Tools and Business Sciences (IWB) at the Technical University in Munich.

Languages

English, German and Russian.

Member

Bar admissions: European Patent Office (EPO); German Patent and Trademark Office (GPTO); German Federal Patent Court (BPatG); German Federal Supreme Court (BGH) in nullity appeal proceedings; German Federal Office for Plant Varieties (BSA); International Bureau of WIPO (IB).

Education

European Qualification Exam (2002); German Patent Bar Exam (2001); Swiss Federal Institute of Technology Zurich, Switzerland (Master of Advanced Studies in IP 1997); University of Basel, Switzerland (Ph.D. in Molecular Biology 1996); Moscow State University, Russia (Diploma in Physics 1993).


Germany: Intellectual property

Patent prosecution

Within: Patent prosecution

Jones Day is particularly well positioned in the pharmaceutical, chemistry and biotechnology areas, which following the departure of Bojan Savic to K&L Gates in April 2018 is handled by practice head Martin Weber and Olga Bezzubova at partner level. Dorothée Weber-Bruls and Andreas Holzwarth-Rochford are the key contacts for matters related to physics, mechanical and electrical engineering and technology, including artificial intelligence. The firm advised Akebia Therapeutics on its patent portfolio for erythropoietin substitutes, partially in cooperation with firm colleagues in the US in order to use a US discovery procedure for opposition proceedings. The team advised SMR Patents on freedom-to-operate analyses of camera systems and semi-autonomous vehicles; the team is now also acting for several of the client’s subsidiaries. Other clients include Sunrise Medical, Celgene and Rational.

[back to top]


Back to index

Legal Developments by:
Jones Day

  • US rules regarding offshore accounts

    The Hiring Incentives to Restore Employment Act 2010, enacted on 18 March 2010, imposes a new US withholding tax and reporting regime, known as the Foreign Account Tax Compliance Act (FATCA). The FATCA regime applies generally to payments made after 31 December 2012, except on obligations (to be defined in future guidance) outstanding on 18 March 2012. Substantial effort is required by foreign entities to bring their worldwide operations and policies into compliance with the FATCA rules as of the effective date.

    - Jones Day

Legal Developments in Germany

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to